title: The nature of opioid involvement in the hemodynamic respiratory and humoral responses to exercise.
abstract: After 30 min rest in the lying position, 12 healthy male volunteers (average age 22 years) received, in a randomized double-blind cross-over protocol, either saline or naloxone (10 mg iv followed by a continuous infusion of 10 mg/hr). Thereafter they rested for a further 30 min in the recumbent position and for 15 min sitting on a bicycle ergometer; they then exercised to exhaustion. At rest plasma levels of adrenocorticotropin (ACTH), cortisol, and aldosterone increased during infusion of naloxone, while body temperature decreased. During exercise the difference in plasma ACTH between naloxone and saline periods was abolished, while the differences in plasma cortisol and aldosterone lost statistical significance. Intra-arterial pressure, heart rate, ventilation, O2 uptake, and CO2 output were continuously monitored throughout the experiment and were not affected by naloxone. This was also the case for several hormonal and biochemical measurements, including those of plasma renin, angiotensin II, norepinephrine, 13,14-dihydro-15-keto-prostaglandin F2 alpha, glucose and lactate, and serum insulin and growth hormone. Exercise performance was not changed by naloxone. In conclusion (1) during exhaustive graded exercise of short duration opioidergic inhibition of the pituitary-adrenocortical axis is probably not sustained, (2) apart from the latter mechanism, the present study does not support the hypothesis that endogenous opioids are involved in various hemodynamic, respiratory, and hormonal responses to this type of exercise.
mesh_terms: D000328:Adult; D001831:Body Temperature; D006439:Hemodynamics; D006801:Humans; D008297:Male; D009270:Naloxone / Q000494:pharmacology / Q000502:physiology*; D009292:Narcotic Antagonists / Q000502:physiology; D009294:Narcotics / Q000502:physiology*; D005082:Physical Exertion; D012119:Respiration; D012146:Rest
chemical_list: D009292:Narcotic Antagonists; D009294:Narcotics; D009270:Naloxone